Company: SINT
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021930
Chunk: 6

Company: Sintx Technologies, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 8
Chunk 6
---
aggregated expense information in the footnotes. Management anticipates that this will enhance the granularity of expense disclosures
but does not expect a material effect on our reported financial position or results of operations. We are reviewing our current expense
classification practices and data collection capabilities to ensure compliance with the new requirements upon adoption.

The
Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on
its consolidated financial position, results of operations or cash flows.

    8

2.
Disposition of TA&T

On
February 19, 2025, the Company entered into an Entity Acquisition Agreement (the “Agreement”) with Tethon Corporation (“Tethon”),
pursuant to which the Company sold to Tethon all the issued and outstanding shares of TA&T in exchange for the assumption by Tethon
of the outstanding liabilities of TA&T. The disposal did not represent a strategic shift that will have a major effect on the Company’s
operations and financials and, therefore, did not qualify for discontinued operations treatment under ASC 205-20.

The
following table summarizes the carrying amounts of the major classes of assets and liabilities of TA&T at the date of sale that were
transferred to the Tethon (in thousands):

 Schedule of Major Classes of Assets
and Liabilities of TA & T at the Date of Sale

    February 19, 2025 
  
    Cash and cash equivalents 
    $4 
  
    Inventories 
     8 
  
    Accounts receivable 
     91 
  
    Right of use asset 
     376 
  
    Property and equipment, net 
     248 
  
    Other assets 
     16 
  
    Total assets sold 
     743 
  
    Accounts payable 
     (26)
  
    Accrued expenses 
     (275)
  
    Operating lease liability 
     (384)
  
    Other liabilities 
     (34)
  
    Total liabilities assumed 
     (719)
  
    Net assets sold 
    $24 

No
consideration was paid other than the assumption by Tethon of the above liabilities. No significant transaction costs were incurred.
No earnout or other contingent consideration arrangements were included in the Agreement.

3.
Business Combinations

On
July 1, 2025, the Company entered into an Asset Purchase Agreement with Sinaptic Surgical, LLC (“Sinaptic Surgical”) and
Sinaptic Holdings, LLC